We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Thailand's biotechnological society will be having another chance to receive
technology transfer from its business partners Novartis which last week signed
a three-year partnership agreement with the Thai government agency BIOTECH,
to develop new medicines based on natural herbs found in Thailand.
The latest South African government budget reportedly envisages a
significant increase in spending to combat HIV/AIDS, with funding for antiretroviral
(ARV) drugs expected to reach ZAR3bn (US$494.59mn) over the next three years.
According to a study carried out by Canada's Institute for Health
Information, the country's drug bill increased 8.8% last year to CAD21.80bn
(US$17.75bn), implying a rise in per capita spending to CAD681.
Poland's generics-dominated drug manufacturing industry expects the
cost of adherence to European Union (EU) directives at some PLN1bn (US$280mn),
equivalent to roughly 7% of market value.
A government committee studying reforms to India's Drugs and Cosmetics
Act could recommend a tightening of protection on data submitted under new drug
applications.
Generic drug maker Aspen Pharmacare plans a joint venture with India's Matrix
Laboratories Ltd to make active pharmaceutical ingredients (APIs), the South
African firm said on Friday.